Healthcare Global Enterprises Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting
12-11-2025 | 06:07 pm
12-11-2025 | 06:07 pm
HCG's board approved Q2 & H1 financial results: consolidated profit for Q2 was ₹20.66 Cr, H1 was ₹44.81 Cr. They also allotted 7,537 ESOP shares and approved up to ₹7 Cr investment in Cancer Care Kenya Limited.
No comments yet. Be the first to comment!
All announcements from Healthcare Global Enterprises Limited
